ミシシッピ州における卵巣がんの臨床試験
ミシシッピ州内の拠点で、卵巣がんに関する6件の研究が参加者を募集しています。
ミシシッピ州内の都市
公式研究テキスト（英語）
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- Baptist Memorial Hospital and Cancer Center-Golden Triangle, Columbus
- Baptist Cancer Center-Grenada, Grenada
- Baptist Memorial Hospital and Cancer Center-Union County, New Albany
- 他2件
被験者募集中第2相
全年齢 · 全性別 · 2026/10/05更新 · NCT05564377Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
- University of Mississippi Medical Center, Jackson
被験者募集中観察研究
18歳以上 · 女性 · 2026/09/29更新 · NCT05051722A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
- University Of Mississippi Medical Center /ID# 276342, Jackson
被験者募集中第2相
18歳以上 · 女性 · 2026/09/29更新 · NCT06890338A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
- University of Mississippi Medical Center, Jackson
被験者募集中第2相
18歳〜99歳 · 女性 · 2026/09/15更新 · NCT07023627Study of Carboplatin and Mirvetuximab Soravtansine in First-Line Treatment of Patients Receiving Neoadjuvant Chemotherapy With Advanced-Stage Ovarian, Fallopian Tube or Primary Peritoneal Cancer
- University of Mississippi Medical Center, Oxford
被験者募集中第2相
18歳以上 · 女性 · 2026/07/14更新 · NCT04606914SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Hattiesburg
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。